Integer Holdings ITGR Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Total sales by Product | ||||||
| Cardiac Rhythm Management & Neuromodulation | $168.26M+4.9% | —— | $169.16M+2.5% | $172M+2.3% | $160.35M+2.2% | |
| Cardio & Vascular | $261.73M+1.1% | —— | $277.15M+15.0% | $286.86M+24.0% | $258.87M+16.7% | |
| Other Markets | $9.58M-47.3% | —— | $21.39M-15.5% | $17.64M-37.9% | $18.18M-37.4% | |
| Sales by Product | ||||||
| Cardiac Rhythm Management & Neuromodulation | $168.26M+4.9% | $167.3M-1.9% | $169.16M+2.5% | $172M+2.3% | $160.35M+2.2% | |
| Other Markets | $9.58M-47.3% | $20.55M-13.2% | $21.39M-15.5% | $17.64M-37.9% | $18.18M-37.4% | |
| Long-Lived Assets by Geography | ||||||
| Ireland | $155.95M+6.7% | $160.51M+14.7% | $158.81M— | $158.03M— | $146.11M+4.4% | |
| Mexico | $47.23M+17.8% | $45.92M+21.4% | $41.87M— | $41.19M— | $40.09M+5.9% | |
| Rest of world | $33.13M+1.9% | $32.55M+16.9% | $28.99M— | $29.45M— | $32.51M+16.7% | |
| United States | $296.83M+7.1% | $297.44M+14.3% | $287.34M— | $283.12M— | $277.26M+6.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Integer Holdings break its business down?
- Integer Holdings (ITGR) reports total sales by product across 3 parts — Cardiac Rhythm Management & Neuromodulation, Cardio & Vascular and Other Markets. Each is extracted from the segment footnotes and tracked over time.
- Where does Integer Holdings's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Integer Holdings's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
